DMEMEDS shared post via Reuters: Novartis to test Alzheimer's drugs in patients without symptoms

ZURICH (Reuters) - Novartis said it would test two experimental Alzheimer's drugs on people with a genetic risk of developing dementia, aiming to gauge whether the treatments can prevent or delay symptoms of the memory-robbing disease. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/ifVLDOQaFr4/story01.htm

Read More